ÃâÒßѧÊÔÌâ
9)?_[|2 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
2MU$OI0| 1. Fas(CD95)/FasL
agGgj>DDd
2. common chain of cytokine receptor
,,c+R?D 3 . TCR/CD3 complex
FP<mFqy 4. negaive selection of thymocytes
J#?`l, 5. artificial active immune
<kCOg8<y
: 6. anti-idiotypic
Gk']Ma2J} 7. IgSF
5W!#,jz 8. Integrin
: i{tqY% 9. chemokine
B,fVNpqo 10. B7/CD28
]!X[[w) ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
nv<t$r 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
k`((6 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
tc0(G~.N 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
g#q7~#9 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
^o87qr0g]
&n'@L9v81 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
60G(jO14 µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
Ay6]vU Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
7?;ZE: 1. B7/CD28
MCAWn
H 2. Th1 subset
fcTg/EXn 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
_;,"!'R`f 4. antibody affinity maturation
V-(*{/^" 5. AP-1
t2Px?S? 6. single chain variable fragment£¨ScFv£©
|'``pq/}_ 7. NK cell receptor
Px3I
+VP 8. Zinkernagel-Doherty phenomenon
S.Q:O{] 9. Ig fold
+NJIi@
10. CD40/CD40L
`MHixQ;j ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
Ob/i_ 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
6:q,JB@i 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
q|}O-A*wa 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
5,pEJ>dDD3 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
}5;/!P_A 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
,9M2'6= 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
CTe!jMZ= 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
'h@&rr@5 Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
1(pv3
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
}mo)OyIX Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
Xf{9rZ+ 1.Co-stimulators (or co-stimulating molecules)
bXeJk]#y 2.NK-kB
N,Js8Z" 3.Immunoglobulin superfamily
j]U~ZAn,K 4.antigen-presenting cell (APC)
VN0KK
1I 5.death domain
+^jm
_+ 6.CCR and CXCR
}(!rB#bf 7.Lectin (or mitogen)
=4sx(< 8.Clusters of differentiation, CD)
{6O}E9 9.B7 family
~xv3R 10.Cytotoxic T lymphocyte, CTL)
ArjRoXDE 11.IL-15 and IL-15 receptor (IL-15R)
4 aE{}jp1 12.MHC restriction
/;TtMQt 13.Affinity-chromatography
>5E1y! 14.Cyctosprin A, CsA
#?`S+YN!q) 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
"%bU74> ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
`\P1Ff@z0 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
?D,j!Hy 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
]rSg,Q>E 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
Pe-rwM Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
vRn]u57O ÃâÒßѧרҵ£º
y\4/M6 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
M6 8foeeN Ïû»¯ÄÚ¿Æ£º
h6IO ;:P) 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
MIyT9",Pl ѪҺ²¡Ñ§×¨Òµ£º
}I MV@z B 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
?S9vYaA$ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
jt(GXgm (רҵ»ù´¡: ÃâÒßѧ)
4<vi@,s Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
Y@<jvH1 1. ADCC(antibody dependent cell-mediated cytotoxicity)
ir>S\VT4 2. »·æß¾úËØ(cyclosporin)
DSWmQQ 3. KIR(killer cell inhibitory receptor)
4\nGWi{2 4. HLDA(human leucocyte differentiation antigen)
c10$5V&@ 5. Interleukin 18(IL-18)
_yX.Apv] 6. ÕûºÏËØ(integrin)
FC~%G&K/q^ 7. Fas/FasL
34[TM 3L]. 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
WbBd<^Q 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
2`%a[t@M. 10. Th1/Th2
9[W >`JKo 11. »ùÒòÒßÃç(DNAÒßÃç)
.)Pul|)d 12. chemokines and chemokine receptor
NZ0 ?0* 13. ÃâÒßÄÍÊÜ
#D%6b 14. ¹²´Ì¼¤·Ö×Ó
wf1p/bpf 15. ËÀÍö½á¹¹Óò(death domain)
}N ).$ ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
NQ;$V:s) 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
EaHJl
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
Y"r728T`K £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
80T2EN:$ £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
~IWdFUKk £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
,nCvA%B! £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
h^q
Zi@L 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
u<N`
;s Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
lKQevoy' ÎÊ´ðÌâ(ÿÌâ25·Ö)
S-ZN}N{,6 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
_Y/*e<bU 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
}<@-= 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
9Li&0E 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£